✦ LIBER ✦

Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu

✍ Scribed by De Grève, J.; Teugels, E.; Geers, C.; Decoster, L.; Galdermans, D.; De Mey, J.; Everaert, H.; Umelo, I.; Veld, P. In’t; Schallier, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9166 Activity of BIBW 2992, an irreversi

✍ De Greve, J.; Teugels, E.; Geers, C.; DeMey, J.; in 'tveld, P.; Decoster, L.; Ta 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

1417 POSTER A Phase II Trial of Afatinib

✍ E.L. Kwak; G.I. Shapiro; S.M. Cohen; C.R. Becerra; H.J. Lenz; S. Gooden; M. Robo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A phase II study of afatinib (BIBW 2992)

✍ Nancy U. Lin, Eric P. Winer, Duncan Wheatley, Lisa A. Carey, Stephen Houston, Da 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 218 KB

Absence of the ERBB2 kinase domain mutat

✍ Jong Woo Lee; Young Hwa Soung; Su Young Kim; Won Sang Park; Suk Woo Nam; Sang Ho 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 62 KB 👁 1 views

573 POSTER Phase I study of BIBW2992, an

✍ R. Plummer; L. Vidal; L. Li; H. Shaw; R. Perrett; M. Shahidi; A. Amelsberg; G. T 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 67 KB

HER2/neu intragenic kinase domain mutati

✍ Altundag, Ozden; Altundag, Kadri; Ozcakar, Bulent; Silay, Yavuz S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 55 KB